MRNA--
SLS--
XBI--
sls mrna market value jump cancer vaccine results
$SLS Just Do The Math Why Did $MRNA Jump $40B in Market Value After Its P3 Cancer Vaccine Results Were Announced For All the Same Reasons $SLS Is Going To And Up Nearly $100B Since From $22 to $280 DO THE MATH Unmet Need Zero Competition 50,000 AML Remission Patients Each Year 2x 4x OS Advantage PRISTINE SAFETY PROFILE Easy SubQ at Home Administration IP RIGHTS until 2037 FDA EU Fast Track Orphan Designation $MRNA $XBI
Disclaimer: The above is a summary showing certain market information. Ainvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing, All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market.Report an Issue

Comments
No comments yet